Risk of Infringing Intellectual Property Rights in Private-Label Products
First written in FY2017. 24 of 25 entries say "Restated". Latest entry: FY2027-H1.
156 other companies' latest entry also says "Restated".
- FY2027-H1RestatedAnnual report
「During the current interim accounting period, there were no new occurrences of the major risks that management recognizes as potentially having a material impact on the company's financial position, operating results or cash flows, among the matters relating to the business and accounting conditions described in the interim report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there have been no new occurrences or material changes in the risk of intellectual property infringement and dispute-related costs concerning its private-label products. - FY2025RestatedAnnual report
「In planning and developing private-label products, we exercise the utmost care to avoid infringing the patent rights, trademark rights, design rights and other rights of manufacturers. However, if a dispute such as litigation arises alleging infringement of these rights, its resolution could require substantial costs and may affect our financial condition and operating results.」
The company continues to disclose the risk of intellectual property infringement involving its own-brand products and related litigation costs. - FY2025-H1RestatedAnnual report
「During the current interim accounting period, there were no new occurrences of the major risks that management recognizes as potentially having a material impact on the company's financial position, operating results or cash flows, among the matters relating to the business and accounting conditions described in the interim report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company reports no new occurrence or material change regarding the risk of intellectual property infringement involving private-label products and related dispute costs. - FY2024-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」
The company states that there have been no new occurrences or material changes concerning the risk of infringement of intellectual property rights in its own-brand products. - FY2023RestatedAnnual report
「In planning and developing private-label products, we exercise the utmost care to avoid infringing the patent rights, trademark rights, design rights and other rights of manufacturers. However, if a dispute such as litigation arises alleging infringement of these rights, its resolution could require substantial costs and may affect our financial condition and operating results.」
The company continues to disclose the risks of intellectual property infringement and litigation costs relating to its private-brand products. - FY2023-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」
The company states that there have been no new occurrences or significant changes regarding the risk of intellectual property infringement involving private-label products and related litigation costs. - FY2022-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2022-Q2RestatedAnnual report
「During the cumulative second-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2022-Q1RestatedAnnual report
「No new business or other risks arose during the cumulative first-quarter period. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2021RestatedAnnual report
「In planning and developing private-brand products, we exercise the utmost care to avoid infringing the patent rights, trademark rights, design rights and other rights of manufacturers. However, if a dispute such as litigation arises alleging infringement of these rights, its resolution could require substantial costs and may affect our financial condition and operating results.」
The company continues to disclose the risks of intellectual property infringement and litigation costs relating to private-brand products. - FY2021-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no newly arising business or other risks. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2021-Q2RestatedAnnual report
「No new business or other risks arose during the cumulative second-quarter period. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2021-Q1RestatedAnnual report
「No new business or other risks arose during the cumulative first-quarter period. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2020RestatedAnnual report
「Although we exercise the utmost care in avoiding infringement of other manufacturers' patent rights, trademark rights, design rights and other intellectual property rights when planning and developing private-brand products, if such infringement leads to litigation or other disputes, substantial costs may be incurred in resolving the matter, which could affect our financial position and operating results.」
The Company continues to disclose the risk of intellectual property infringement involving private-label products and related dispute costs. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2020-Q2RestatedAnnual report
「No new business or other risks arose during the cumulative second-quarter period. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2019RestatedAnnual report
「Although we exercise the utmost care in avoiding infringement of other manufacturers' patent rights, trademark rights, design rights and other intellectual property rights when planning and developing private-brand products, if such infringement leads to litigation or other disputes, substantial costs may be incurred in resolving the matter, which could affect our financial position and operating results.」
The Company continues to disclose the risk of intellectual property infringement involving private-label products and related dispute costs. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2019-Q2RestatedAnnual report
「No new business or other risks arose during the cumulative second-quarter period. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2019-Q1RestatedAnnual report
「No new business or other risks arose during the cumulative first-quarter period. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in existing risks, including the risk of intellectual property infringement involving private-label products. - FY2018RestatedAnnual report
「Although we exercise the utmost care in avoiding infringement of other manufacturers' patent rights, trademark rights, design rights and other intellectual property rights when planning and developing private-brand products, if such infringement leads to litigation or other disputes, substantial costs may be incurred in resolving the matter, which could affect our financial position and operating results.」
The company continues to disclose the risks of intellectual property infringement and litigation costs relating to private-brand products. - FY2018-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no newly arising business or other risks. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risk of intellectual property infringement involving private-label products. - FY2018-Q2RestatedAnnual report
「There were no newly arising business or other risks during the cumulative second quarter. There were also no material changes to the business or other risks described in the securities report for the previous fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2018-Q1RestatedAnnual report
「No new business or other risks arose during the cumulative first quarter. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company stated that there had been no material changes regarding the risk of intellectual property infringement involving private-label products. - FY2017First statedAnnual report
「Although we exercise the utmost care in avoiding infringement of other manufacturers' patent rights, trademark rights, design rights and other intellectual property rights when planning and developing private-brand products, if such infringement leads to litigation or other disputes, substantial costs may be incurred in resolving the matter, which could affect our financial position and operating results.」
The company identifies infringement of third-party patent, trademark and design rights, and related litigation costs, as risks associated with the planning and development of PB products.